Welcome to our dedicated page for AI / ML Innovations news (Ticker: AIMLF), a resource for investors and traders seeking the latest updates and insights on AI / ML Innovations stock.
AI/ML Innovations Inc. (AIMLF) is a pioneering company in the artificial intelligence (AI) and machine learning (ML) sectors, dedicated to acquiring and advancing technologies that address critical societal needs. Established to capitalize on the burgeoning fields of AI and ML, the company focuses on emerging digital health and wellbeing solutions that leverage AI, cloud computing, and digital platforms to revolutionize healthcare management.
AI/ML Innovations Inc. is committed to transforming healthcare through strategic partnerships and innovative initiatives. Its majority-owned subsidiary, Health Gauge Inc., is at the forefront of health tech innovation. Health Gauge has developed the ‘Follow Your Heart’ smartwatch, a wellness tool that uses proprietary AI PrecisionPulse Neural Network measurement technology to provide non-invasive, medical-grade accurate blood pressure readings. This product is a significant step forward in addressing the hypertension epidemic, offering users convenient and precise health monitoring.
In addition to consumer products, AI/ML Innovations Inc. supports healthcare innovators and researchers with advanced tools like The Pulse Guru, a smart sensor wearable that offers unparalleled access to raw ECG and PPG signal data. This device is instrumental for professionals needing detailed cardiovascular insights.
The company’s strategic growth also includes a recent acquisition of Naiad Labs Inc.’s product division, integrating the Long ECG Neural Net, which drastically reduces the time needed to label long ECGs, enhancing accuracy and efficiency in cardiovascular diagnostics.
AI/ML Innovations Inc. continues to expand its technological footprint with the launch of NeuralCloud Solutions Incorporated, a subsidiary focused on merging smart sensor technology with digital health. The company aims to make high-quality personal biometric data accessible to individuals globally, supported by robust AI and neural network technologies.
AI/ML Innovations Inc. trades on the Canadian Securities Exchange under the symbol AIML, the OTCQB Venture Market under AIMLF, and the Frankfurt Stock Exchange under 42FB. For more information, visit the company's website.
AI/ML Innovations Inc. (AIML) has finalized the acquisition of cutting-edge technology from Naiad Lab, a deal completed on June 3, 2024. The acquisition includes Naiad's proprietary Long ECG Neural Net (L-ECG NN) for detailed cardiovascular insights and the Neural Network Store (NNStore), a subscription-based AI analysis platform.
Key aspects of the acquisition include AIML issuing 6.7 million common shares valued at $335,000 to Naiad and creating a new subsidiary to manage the assets. Additionally, AIML will pay a royalty to Naiad based on revenue generated from the L-ECG NN technology and has granted 700,000 stock options to Naiad's management. The deal involves contingent shares that convert to common shares if certain milestones are met, including FDA approval and revenue targets.
This strategic acquisition aims to enhance AIML's portfolio and position it at the forefront of AI-driven healthcare innovations.
AI/ML Innovations has launched The Neural Net Store, an online commercial portal offering flexible, affordable access to its AI-driven healthcare solutions. The NNStore features products like the Follow Your Heart suite for Blood Pressure measurement and a Long ECG Neural Network analytical tool. Users can access these tools via downloadable APIs for integration into third-party applications or through a cloud-based Neural Net Service (NNaaS). This service is designed to eliminate barriers in adopting AI solutions in healthcare, offering options for both infrequent and frequent users, including developers and healthcare organizations. The introduction of the NNStore aims to facilitate easier implementation of AI technologies, thereby driving innovation in healthcare.
AI/ML Innovations has announced an agreement with Moonshot, appointing Paul Duffy as CEO. The contractual agreement includes a $125,000 signing bonus in shares, another $125,000 in shares on the second anniversary, and annual retention fees of $250,000 and $300,000 over two years, payable quarterly in shares. Additionally, Moonshot receives options to purchase up to 1.5 million shares at $0.20 each, vesting in three installments contingent on specific milestones. The issuance of shares and options requires Canadian Securities Exchange approval.
AI/ML Innovations has announced the formation of a new subsidiary, NeuralCloud Solutions. This subsidiary aims to capitalize on the convergence of the global smart sensor market and the digital health industry by monetizing recently acquired assets from Naiad Labs. The smart sensors market, valued at USD 52.4 billion in 2023, is expected to reach USD 160.3 billion by 2030. The global digital health market, valued at USD 217 billion in 2022, is projected to reach USD 1,592 billion by 2032. NeuralCloud will focus on delivering personalized health intelligence through advanced sensor technologies and AI. Esmat Naikyar has been appointed as President and Chief Product Officer of NeuralCloud.
AI/ML Innovations Inc. introduces its proprietary Long ECG Neural Net technology, reducing labeling of long ECGs from days to minutes. The technology offers high accuracy, depth, and insight into cardiac data, catering to cardiologists, researchers, and pharmaceuticals. With over 100 million ECGs performed annually in the USA, this innovation aims to revolutionize ECG analysis, potentially detecting and predicting cardiovascular diseases. The company plans for FDA approval, online access, and accelerating diagnoses and predictions.
AI/ML Innovations Inc. has entered into a binding Letter of Intent to acquire strategic healthcare assets from Naiad Labs Inc., including a Long ECG Neural Net that reduces reading time to under 5 minutes. The acquisition involves issuing 6,700,000 Common Shares valued at $469,000 to Naiad, creating a new operating subsidiary, paying a streaming royalty, and granting stock options to Naiad management. The deal is non-arm's length due to AIML's Interim CPO's association with Naiad Labs. The closing is subject to due diligence and regulatory approvals, aiming for completion by May 30, 2024.
FAQ
What is the current stock price of AI / ML Innovations (AIMLF)?
What is the market cap of AI / ML Innovations (AIMLF)?
What does AI/ML Innovations Inc. do?
What is 'Follow Your Heart'?
What are the key features of The Pulse Guru?
What recent acquisitions has AI/ML Innovations Inc. made?
What is NeuralCloud Solutions Incorporated?
How does AI/ML Innovations Inc. plan to expand its market presence?
Where can I buy AI/ML Innovations Inc. products?
What is the Neural Net Store?
How does AI/ML Innovations Inc. support the healthcare industry?
What is the significance of the Long ECG Neural Net?
